ALPI-Inst. de Rehabilitacion Marcelo Fitte

Buenos Aires C1425BWO

0 studies enrolling now · 2 studies all time

What they study most

Alzheimer's Disease, Relapsing Multiple Sclerosis

Studies at this site

• A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed
• A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease — Completed